Predictive factors for response to chemotherapy in colorectal cancer patients

Critical Reviews in Oncology/hematology
Bruno VincenziGiuseppe Tonini

Abstract

Colorectal cancer represents a major health problem in the western world. A lot of drugs have been employed in treatment of this disease, but only few data are available about predictive factors for response to anticancer treatments in colorectal cancer. Aim of this paper is to review the main data about this investigation field. Using a Medline database search (1966-2003) we reviewed all the relevant papers that investigate clinical and molecular predictors for response to the main drugs used in the treatment of colorectal cancer patients, both in adjuvant and in advanced setting. Moreover we comprehensively reviewed all the data published in abstract form during the most significant international meetings. Our review put in evidence the most important predictive factors for response in colorectal cancer patients treated with anticancer chemotherapy both in adjuvant and in advanced setting. The predictive factors are clustered on the basis of the different anticancer drugs. The results of this review provide the rationale basis for personalizing anticancer treatment in colorectal cancer patients by molecular and clinical features, aiming to improve response rate and reduce toxicities.

References

Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W GrafR Bergström
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J J LokichJ G Fryer
Jan 1, 1994·Cancer Treatment Reviews·G A SotosC J Allegra
Jan 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T R BurokerD H Gesme
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A BeckG Milano
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R B Diasio, Z Lu
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P G JohnstonC J Allegra
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W GrafB Glimelius
Jul 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A WebbJ Bensted
Oct 18, 1996·Cell·K W Kinzler, B Vogelstein
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A F SobreroJ R Bertino
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y M RustumS Seeber
Jan 1, 1997·British Journal of Cancer·H J SchneiderP A Clarke
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H Bleiberg
Oct 23, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C G LeichmanP V Danenberg
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Meta-analysis Group In CancerE Levy
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R MetzgerL Leichman
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P RougierM Ducreux
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R GorlickJ R Bertino
May 20, 1998·Journal of the National Cancer Institute·H J AndreyevP A Clarke
Aug 8, 1998·Genes & Development·N Dyson
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R A PopescuD Cunningham
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S GiacchettiF Lévi
Jan 13, 2000·The New England Journal of Medicine·R GryfeS Gallinger
Feb 5, 2000·Biochimica Et Biophysica Acta·H Müller, K Helin
Mar 14, 2000·Critical Reviews in Oncology/hematology·B T HillA Kruczynski
Jul 27, 2000·Annals of the New York Academy of Sciences·E A SausvilleA M Senderowicz
Sep 28, 2000·The New England Journal of Medicine·L B SaltzL L Miller
Sep 29, 2000·International Journal of Cancer. Journal International Du Cancer·U ManneW E Grizzle
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S GordonD Adelman

❮ Previous
Next ❯

Citations

Jun 14, 2005·Trends in Molecular Medicine·Simone MocellinDonato Nitti
Mar 4, 2010·Molecular Cancer Therapeutics·Anna E VilgelmAlexander I Zaika
Feb 20, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Evgeny N Imyanitov, Vladimir M Moiseyenko
Dec 19, 2008·Gastroenterología y hepatología·Laura Sempere, Rodrigo Jover

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.